Remove company quest-diagnostics
article thumbnail

Quest Expands in Cancer Testing With $300M Haystack Oncology Acquisition

MedCity News

Quest Diagnostics is acquiring liquid biopsy company Haystack Oncology. The startup’s technology is used for identifying cancer patients who need adjuvant therapy.

Patients 104
article thumbnail

Diagnostics Market Expectations and Opportunities Post Pandemic

PM360

The healthcare industry has been transformed by the COVID-19 pandemic, and the diagnostic market is no exception. This has led to significant changes in the healthcare diagnostics market and has created new opportunities and challenges for pharma executives. The COVID-19 pandemic, however, changed all of that.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

annalise.ai appoints proven global healthcare leader as CEO, officially launches US team following FDA clearances

Legacy MEDSearch

annalise.ai, the global radiology AI company with rapidly growing presence in Asia- Pacific, Europe and the United Kingdom, today announced the appointment of accomplished healthcare technology executives Lakshmi Gudapakkam as Chief Executive Officer and clinical strategist Dr Rick Abramson as Chief Medical Officer.

article thumbnail

Unleashing the power of computational tools in rare disease

Clarivate

In this era of real-world data (RWD) and precision medicine, the quest to unlock the mysteries of rare diseases and tailor treatments to individual patients has never been more promising. One of the topics discussed was how companies can ensure data quality, accuracy, and completeness when dealing with rare diseases.

article thumbnail

Prolira Announces FDA Clearance of the DeltaScan® Brain State Monitor for Detecting Acute Encephalopathy (Acute Brain Failure), a Condition Affecting Millions of Hospitalized Patients 60 and Older

Legacy MEDSearch

“Managing acute encephalopathy is challenging as symptoms are often overlooked and the diagnostic approaches are largely subjective and ineffective, resulting in delayed diagnosis and treatment. Our clients include both blue-chip companies and innovative startups within the MedTech space. For more information, visit [link].

FDA 52
article thumbnail

Meet Our Mentor: Bryan Stewart

MedTechVets

My first role out of the military was with Humana (a large health insurance company). After my stint at Humana, I joined Abbott Laboratories in a sales role serving in their Diagnostics Division.

article thumbnail

What Does the Metaverse Mean to Pharma?

PM360

At Meta Connect 2023, held on September 27, the company announced its new Meta Quest 3 headset along with an AI chatbot with 25 different personalities that will debut on WhatsApp, Messenger, and Instagram, but will eventually make its way to the metaverse in the form of an avatar users can talk to, according to Zuckerberg.

Pharma 97